Skip to content

The influence of implant length on the outcomes of total hip arthroplasty

Can Arthroplasty Stem INfluence Outcome? (CASINO): a randomised controlled equivalence trial of 125mm vs 150mm Exeter stems in total hip arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13154542
Enrollment
220
Registered
2017-07-14
Start date
2017-06-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthritis Musculoskeletal Diseases Coxarthrosis [arthrosis of hip]

Interventions

Patients will be randomised on a 1:1 ratio to receive either an ‘original’ (150mm) or ‘short’ (125mm) ExeterTM stem as part of routine total hip arthroplasty at the study centre. Randomisation will be
using the posterior approach, ExeterTM femoral component and ContemporaryTM acetabular component (Stryker). All implants will be cemented. The routine post-operative patient care protocol of the study

Sponsors

ACCORD; The University of Edinburgh & NHS Lothian
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Planned total hip replacement for osteoarthritis 2. Planned primary hip arthroplasty with standard implants 3. Patients aged 45-80 4. Patient willing and able to comply to the study protocol

Exclusion criteria

Exclusion criteria: 1. Dysplasia of the hip/acetabulum 2. Requirement for acetabular bone grafting 3. Planned bilateral procedures within the trial period 4. Activity-limiting pain in either knee or contralateral hip 5. Procedures done for pain relief (such as for patients with no walking capacity) 6. Already recruited to the trial

Design outcomes

Primary

MeasureTime frame
Patient reported function, measured using the Oxford Hip Score at baseline, 1 year and 2 years

Secondary

MeasureTime frame
1. Quality of life, measured using the EQ5D-5L questionnaire at baseline, 1 year and 2 years 2. Pain, measured using the visual analogue scale at baseline, 1 year and 2 years 3. Joint awareness, measured using the Forgotten Joint Score-12 at baseline, 1 year and 2 years 4. Satisfaction, measured using a satisfaction Likert response scale at 1 and 2 years 5. Radiographic implant position, measured using AP pelvis radiographs at 1 year

Countries

Scotland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026